XYL

Xylem Inc

Add to Watchlist

Advanced Chart

142.500

-0.15(-0.105%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

142.670

Open

142.200

VWAP

142.07

Vol

87.39K

Mkt Cap

34.72B

Low

141.920

Amount

12.41M

EV/EBITDA(TTM)

19.60

Total Shares

242.45M

35.78B

EV/OCF(TTM)

29.23

P/S(TTM)

3.98

Xylem Inc. is a water technology company. The Company designs, manufactures and services engineered products and solutions across a range of critical applications, primarily in the water sector. The Company’s Water Infrastructure segment focuses on the transportation and treatment of water, offering a range of products including water, wastewater and storm water pumps, treatment equipment, and controls and systems. Its Applied Water segment's products include pumps, valves, heat exchangers, controls and dispensing equipment. Its Measurement & Control Solutions segment develops advanced technology solutions that enable intelligent use and conservation of critical water and energy resources as well as analytical instrumentation used in the testing of water. The Company’s Integrated Solutions & Services segment provides equipment systems for industrial needs, full-scale outsourcing of operations and maintenance and municipal services, including odor and corrosion control services.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

2.19B

+5.94%

1.106

+7.33%

2.36B

+4.45%

1.308

+10.84%

2.22B

+5.36%

1.226

+10.44%

Estimates Revision

The market is revising Upward the revenue expectations for Xylem Inc. (XYL) for FY2025, with the revenue forecasts being adjusted by 2.21% over the past three months. During the same period, the stock price has changed by 11.98%.

Revenue Estimates for FY2025

Revise Upward

+2.21%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+3.52%

In Past 3 Month

Stock Price

Go Up

+11.98%

In Past 3 Month

12 Analyst Rating

9.47% Upside

Wall Street analysts forecast XYL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XYL is 156.00 USD with a low forecast of 125.00 USD and a high forecast of 175.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

9 Buy

3 Hold

0 Sell

Strong Buy

9.47% Upside

Current: 142.500

Low

125.00

Averages

156.00

High

175.00

9.47% Upside

Current: 142.500

Low

125.00

Averages

156.00

High

175.00

UBS

Buy

maintain

$164 -> $168

2025-08-05

Reason

UBS

Price Target

$164 -> $168

2025-08-05

maintain

Buy

Reason

UBS raised the firm's price target on Xylem to $168 from $164 and keeps a Buy rating on the shares. Xylem's Q2 results indicate the company is still flowing through relatively smooth waters, the analyst tells investors in a research note.

Baird

Michael Halloran

maintain

$146 -> $171

2025-08-01

Reason

Baird

Michael Halloran

Price Target

$146 -> $171

2025-08-01

maintain

Reason

Baird analyst Michael Halloran raised the firm's price target on Xylem to $171 from $146 and keeps an Outperform rating on the shares. The firm updated its model following strong Q2 results which showed resilience in its outlook.

Oppenheimer

Outperform

maintain

$150 -> $162

2025-08-01

Reason

Oppenheimer

Price Target

$150 -> $162

2025-08-01

maintain

Outperform

Reason

Oppenheimer raised the firm's price target on Xylem to $162 from $150 and keeps an Outperform rating on the shares. The firm notes shares rose 10.7% after Xylem reported Q2 adjusted EPS of $1.26 and lifted 2025 guidance ranges. Organic revenue grew 6%, highlighted by double-digit growth in M&CS. Management raised its full-year revenue outlook to $8.9B-$9.0B from $8.6B-$8.7B, with organic growth expected at +4% year-over-year.

RBC Capital

Outperform

maintain

$155 -> $169

2025-08-01

Reason

RBC Capital

Price Target

$155 -> $169

2025-08-01

maintain

Outperform

Reason

RBC Capital raised the firm's price target on Xylem to $169 from $155 and keeps an Outperform rating on the shares. The company delivered a clean, broad-based operating beat and raise while its organic sales/margins exceeded the firm's model across all four segments, showcasing healthy demand and strong execution, the analyst tells investors in a research note.

Stifel

Buy

maintain

$141 -> $162

2025-07-21

Reason

Stifel

Price Target

$141 -> $162

2025-07-21

maintain

Buy

Reason

Stifel raised the firm's price target on Xylem to $162 from $141 and keeps a Buy rating on the shares. Management team meetings and commentary as well as the firm's channel checks indicate "solid, stable demand" and the firm expects this to lead to many companies being comfortable enough to raise guidance on Q2 earnings calls, the analyst tells investors in a preview for the Diversified Industrials group.

Citi

NULL

Buy

maintain

$137 -> $152

2025-07-14

Reason

Citi

Price Target

$137 -> $152

2025-07-14

maintain

NULL

Buy

Reason

Citi raised the firm's price target on Xylem to $152 from $137 and keeps a Buy rating on the shares. The firm adjusted targets in the industrial conglomerate group as part of a Q2 earnings preview. It expects most in the sector to report solid results and slightly increase 2025 earnings outlooks.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Xylem Inc (XYL.N) is 28.02, compared to its 5-year average forward P/E of 33.10. For a more detailed relative valuation and DCF analysis to assess Xylem Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

33.10

Current PE

28.02

Overvalued PE

39.79

Undervalued PE

26.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

19.06

Current EV/EBITDA

17.70

Overvalued EV/EBITDA

22.42

Undervalued EV/EBITDA

15.71

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

3.36

Current PS

3.78

Overvalued PS

3.86

Undervalued PS

2.87